Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease
Annales Pharmaceutiques Françaises · 2024
DOI: 10.1016/j.pharma.2024.02.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales Pharmaceutiques Françaises, 2024. Verfasst von Bitasta Mandal und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata 700126, India. Electronic address: bitscool27@…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 160 Literaturangaben.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is described by too much hepatic fat deposition causing steatosis, which further develops into nonalcoholic steatohepatitis (NASH), defined by necroinflammation and fibrosis, progressing further to hepatic cirrhosis, hepatocellular carcinoma, and liver failure. NAFLD is linked to different aspects of the metabolic syndrome like obesity, insulin resistance, hypertension, and dyslipidemia, and its pathogenesis involves several elements including diet, obesity, disruption of lipid homeostasis, and a high buildup of triglycerides and other lipids in liver cells. It is therefore linked to an increase in the susceptibility to developing diabetes mellitus and cardiovascular diseases. Several interventions exist regarding its management, but the availability of natural sources through diet will be a benefit in dealing with the disorder due to the immensely growing dependence of the population worldwide on natural sources owing to their ability to treat the root cause of the disease. Anthocyanins (ACNs) are naturally occurring polyphenolic pigments that exist in the form of glycosides, which are the glucosides of anthocyanidins and are produced from flavonoids via the phenyl propanoid pathway. To understand their mode of action in NAFLD and their therapeutic potential, the literature on in vitro, in vivo, and clinical trials on naturally occurring ACN-rich sources was exhaustively reviewed. It was concluded that ACNs show their potential in the treatment of NAFLD through their antioxidant properties and their efficacy to control lipid metabolism, glucose homeostasis, transcription factors, and inflammation. This led to the conclusion that ACNs possess efficacy in the amelioration of NAFLD and the various features associated with it. However, additional clinical trials are required to justify the potential of ACNs in NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata 700126, India. Electronic address: bitscool27@gmail.com.
- School of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata 700126, India. Electronic address: rdas.jupharmtech@gmail.com.
- School of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata 700126, India. Electronic address: sandip1706@yahoo.com.
Zitieren
APA
Mandal, B., Das, R., & Mondal, S. (2024). Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.02.005
Vancouver
Mandal B, Das R, Mondal S. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises. 2024. doi:10.1016/j.pharma.2024.02.005
BibTeX
@article{Mandal2024,
author = {Mandal, Bitasta and Das, Rakesh and Mondal, Sandip},
title = {Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease},
journal = {Annales Pharmaceutiques Françaises},
year = {2024},
doi = {10.1016/j.pharma.2024.02.005}
}
EUVIMED